BIOMARIN PHARMACEUTICAL INC Accrued Liabilities, Current
BIOMARIN PHARMACEUTICAL INC (BMRN) had Accrued Liabilities, Current of $109.63 million as of 2015-06-30, per its 10-Q filed 2015-08-05.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2015-08-05
- 2015-06-30: Accrued Liabilities, Current $109.63M.
- 2015-03-31: Accrued Liabilities, Current $106.46M.
- 2014-12-31: Accrued Liabilities, Current $98.49M.
- 2014-09-30: Accrued Liabilities, Current $78.06M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2015-06-30 | $109.63M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $106.46M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $98.49M 10-Q · filed 2015-08-05 |
| 2014-09-30 | $78.06M 10-Q · filed 2014-10-28 |
| 2014-06-30 | $79.34M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $64.39M 10-Q · filed 2014-05-02 |
| 2013-12-31 | $58.41M 10-K · filed 2015-03-02 |
| 2013-09-30 | $58.67M 10-Q · filed 2013-10-28 |
| 2013-06-30 | $52.10M 10-Q · filed 2013-07-29 |
| 2013-03-31 | $44.34M 10-Q · filed 2013-04-29 |
| 2012-12-31 | $43.16M 10-K · filed 2014-02-26 |
| 2012-09-30 | $36.38M 10-Q · filed 2012-10-29 |
| 2012-06-30 | $32.45M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $26.98M 10-Q · filed 2012-04-30 |
| 2011-12-31 | $23.85M 10-K · filed 2013-02-26 |
| 2011-09-30 | $18.18M 10-Q · filed 2011-10-31 |
| 2011-06-30 | $19.92M 10-Q · filed 2011-08-01 |
| 2010-12-31 | $24.41M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |